Musings from The Power List: Adrián de la Fuente Ballesteros
-
October 16, 2026
-
5 min
October 16, 2026
Contamination in 22 lots of the injection may cause pulmonary embolism or vascular occlusion; no related adverse events reported.
by Mouj Hijazi
October 15, 2026
Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the HER2Climb-05 trial and how it impacts treatment for HER2+ metastatic breast cancer
October 15, 2026